Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?
10:48am, Wednesday, 07'th Jun 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
4 Solid Profitable Stocks to Invest in Using Net Income Ratio
08:53am, Friday, 02'nd Jun 2023
Tecnoglass (TGLS), Amphastar Pharmaceuticals (AMPH), Turkcell Iletisim Hizmetleri (TKC) and Copa Holdings (CPA) have been selected as the top picks with a high net income ratio.
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
04:15pm, Wednesday, 31'st May 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner SVP of Corp. Communication, will participate in
Looking for a Growth Stock? 3 Reasons Why Amphastar (AMPH) is a Solid Choice
01:54pm, Tuesday, 23'rd May 2023
Amphastar (AMPH) possesses solid growth attributes, which could help it handily outperform the market.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
09:08am, Tuesday, 23'rd May 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
Is Amphastar Pharmaceuticals (AMPH) Outperforming Other Medical Stocks This Year?
11:20am, Monday, 22'nd May 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Amphastar (AMPH) Is a Great Choice for 'Trend' Investors, Here's Why
10:39am, Monday, 22'nd May 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, Amphastar (AMPH) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2023 Earnings Call Transcript
02:13pm, Saturday, 13'th May 2023
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Dan Dischner - VP of HR & Corporate Communication William Peters - CFO, Execu
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
07:07pm, Tuesday, 09'th May 2023
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.47 per share a year ago.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023
04:30pm, Wednesday, 03'rd May 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 3, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2023 ended March 31, 2023, afte
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?
11:28am, Wednesday, 26'th Apr 2023
Here is how Amphastar Pharmaceuticals (AMPH) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
Eli Lilly to sell Baqsimi diabetes drug to Amphastar for around $1 billion
12:30pm, Monday, 24'th Apr 2023
Eli Lilly and Co (NYSE:LLY) revealed that it will sell Baqsimi, its nasal treatment for severe hypoglycemia in people with diabetes, to Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) for around $1 billio
Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar
06:54am, Monday, 24'th Apr 2023
Shares of Eli Lilly & Co. LLY gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to sell its hypoglycemia treatment for people with diabetes Baqsimi to Amphastar Pharm
Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023
12:00am, Monday, 24'th Apr 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 24, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will provide a Business update and hold a Conference call today, Monday, A
3 Profitable Stocks Worth a Buy Using Net Income Ratio
08:22am, Friday, 21'st Apr 2023
Amphastar Pharmaceuticals (AMPH), Alpha Metallurgical Resources (AMR) and Riley Exploration Permian (REPX) have been selected as the top picks with a high net income ratio.
